- Details
- Description
LuciNinted 100 mg (Nintedanib) is a prescription antifibrotic medicine used to slow the progression of certain chronic fibrosing lung diseases, including idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated ILD. Nintedanib works by inhibiting specific tyrosine kinases involved in pathways that contribute to fibrosis and abnormal tissue remodeling.
LuciNinted 100 mg is available as an oral capsule and should be taken as directed by a healthcare professional, generally with food. The 100 mg strength may be prescribed when dose reduction is appropriate due to tolerability or other clinical considerations.
Active ingredient: Nintedanib 100 mg
Dosage form: Oral capsule
Category: Antifibrotic agent
Prescription status: Prescription medicine
Use only under medical supervision. Common adverse effects may include diarrhea, nausea, abdominal discomfort, decreased appetite, and elevated liver enzymes. Regular medical monitoring may be required during treatment.
